{"id":3233,"date":"2024-04-17T10:40:50","date_gmt":"2024-04-17T08:40:50","guid":{"rendered":"https:\/\/invivo.partners\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"},"modified":"2024-04-17T11:29:50","modified_gmt":"2024-04-17T09:29:50","slug":"telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer","status":"publish","type":"post","link":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","title":{"rendered":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3220 size-medium alignleft\" src=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg\" alt=\"\" width=\"275\" height=\"300\" srcset=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg 275w, https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-171x187.jpg 171w, https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221.jpg 732w\" sizes=\"auto, (max-width: 275px) 100vw, 275px\" \/><\/p>\n<ul>\n<li><strong>Michael es un profesional experimentado en el \u00e1mbito de la transferencia de tecnolog\u00eda y capital de riesgo, conectando h\u00e1bilmente la investigaci\u00f3n cient\u00edfica con la innovaci\u00f3n comercial.<\/strong><\/li>\n<li><strong>Michael est\u00e1 asumiendo el cargo de CEO, despu\u00e9s de demostrar un liderazgo exitoso en el desarrollo de productos de terapia g\u00e9nica.<\/strong><\/li>\n<\/ul>\n<p>Mas <a href=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/20240417_PR-Telomere.pdf\" target=\"_blank\" rel=\"noopener\">info<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Michael es un profesional experimentado en el \u00e1mbito de la transferencia de tecnolog\u00eda y capital de riesgo, conectando h\u00e1bilmente la investigaci\u00f3n cient\u00edfica con la innovaci\u00f3n comercial. Michael est\u00e1 asumiendo el cargo de CEO, despu\u00e9s de demostrar un liderazgo exitoso en el desarrollo de productos de terapia g\u00e9nica. Mas info<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[501],"tags":[],"class_list":["post-3233","post","type-post","status-publish","format-standard","hentry","category-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Michael es un profesional experimentado en el \u00e1mbito de la transferencia de tecnolog\u00eda y capital de riesgo, conectando h\u00e1bilmente la investigaci\u00f3n cient\u00edfica con la innovaci\u00f3n comercial. Michael est\u00e1 asumiendo el cargo de CEO, despu\u00e9s de demostrar un liderazgo exitoso en el desarrollo de productos de terapia g\u00e9nica. Mas info\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T08:40:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-17T09:29:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg\" \/>\n<meta name=\"author\" content=\"Bego\u00f1a Aguirre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bego\u00f1a Aguirre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"},\"author\":{\"name\":\"Bego\u00f1a Aguirre\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\"},\"headline\":\"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO\",\"datePublished\":\"2024-04-17T08:40:50+00:00\",\"dateModified\":\"2024-04-17T09:29:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"},\"wordCount\":65,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\",\"url\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\",\"name\":\"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2024-04-17T08:40:50+00:00\",\"dateModified\":\"2024-04-17T09:29:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\",\"name\":\"Bego\u00f1a Aguirre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"caption\":\"Bego\u00f1a Aguirre\"},\"url\":\"https:\/\/invivo.partners\/es\/author\/bego\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","og_locale":"es_ES","og_type":"article","og_title":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners","og_description":"Michael es un profesional experimentado en el \u00e1mbito de la transferencia de tecnolog\u00eda y capital de riesgo, conectando h\u00e1bilmente la investigaci\u00f3n cient\u00edfica con la innovaci\u00f3n comercial. Michael est\u00e1 asumiendo el cargo de CEO, despu\u00e9s de demostrar un liderazgo exitoso en el desarrollo de productos de terapia g\u00e9nica. Mas info","og_url":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","og_site_name":"Invivo Partners","article_published_time":"2024-04-17T08:40:50+00:00","article_modified_time":"2024-04-17T09:29:50+00:00","og_image":[{"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg"}],"author":"Bego\u00f1a Aguirre","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Bego\u00f1a Aguirre","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"},"author":{"name":"Bego\u00f1a Aguirre","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee"},"headline":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO","datePublished":"2024-04-17T08:40:50+00:00","dateModified":"2024-04-17T09:29:50+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"},"wordCount":65,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","url":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","name":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2024-04-17T08:40:50+00:00","dateModified":"2024-04-17T09:29:50+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"Telomere Therapeutics nombra al Dr. Michael Tadros como CEO"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee","name":"Bego\u00f1a Aguirre","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","caption":"Bego\u00f1a Aguirre"},"url":"https:\/\/invivo.partners\/es\/author\/bego\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/3233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/comments?post=3233"}],"version-history":[{"count":5,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/3233\/revisions"}],"predecessor-version":[{"id":3255,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/3233\/revisions\/3255"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=3233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/categories?post=3233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tags?post=3233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}